Why the study?
Does chronic kidney disease affect safety and clinical outcomes in patients undergoing first catheter ablation for atrial fibrillation?
Does chronic kidney disease affect safety and clinical outcomes in patients undergoing first catheter ablation for atrial fibrillation?
Catheter ablation for atrial fibrillation in patients with chronic kidney disease has a similar 30-day procedural safety profile and 1-year efficacy as in those without CKD, though it is associated with a higher risk of early heart failure hospitalization.
No takes yet. Share an insight, caveat, or question.
CKD was associated with higher AF ablation risks; leaves open whether benefits justify use pending prospective trials.
Ullal et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: